|
Volumn 9, Issue 10, 2008, Pages 1551-1555
|
Protective effect of a GRK5 polymorphism on heart failure and its interaction with β-adrenergic receptor antagonists
|
Author keywords
Adrenergic antagonists; Heart failure; Personalized medicine; Pharmacogenomics; Translation research
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
G PROTEIN COUPLED RECEPTOR KINASE 2;
G PROTEIN COUPLED RECEPTOR KINASE 5;
ISOPRENALINE;
AFRICAN AMERICAN;
AMINO ACID SUBSTITUTION;
ARTICLE;
DISEASE COURSE;
DRUG RESPONSE;
DRUG SENSITIZATION;
ETHNIC DIFFERENCE;
GENETIC POLYMORPHISM;
GENETIC VARIABILITY;
HEART FAILURE;
HEART PROTECTION;
HUMAN;
MUTATIONAL ANALYSIS;
NONHUMAN;
OUTCOME ASSESSMENT;
PHARMACOGENETICS;
PHENOTYPE;
SIGNAL TRANSDUCTION;
SINGLE NUCLEOTIDE POLYMORPHISM;
SURVIVAL;
AFRICAN AMERICANS;
AMINO ACID SUBSTITUTION;
ANIMALS;
ASIAN CONTINENTAL ANCESTRY GROUP;
CHO CELLS;
CRICETINAE;
CRICETULUS;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
FEMALE;
G-PROTEIN-COUPLED RECEPTOR KINASE 5;
GENETIC VARIATION;
HEART FAILURE;
HUMANS;
LEUCINE;
MALE;
MICE;
MICE, TRANSGENIC;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
RECEPTORS, ADRENERGIC, BETA;
SEQUENCE ANALYSIS, DNA;
SIGNAL TRANSDUCTION;
TRANSFECTION;
UNITED STATES;
|
EID: 55449130234
PISSN: 14622416
EISSN: 17448042
Source Type: Journal
DOI: 10.2217/14622416.9.10.1551 Document Type: Article |
Times cited : (6)
|
References (6)
|